Echsosense develops two types of diagnostic ultrasound devices: the EchoSense Transthoracic Parametric Doppler (TPD) and the EchoSense D-Holter that is designed to replace the standard ECG based Holter. Both devices are expected to be commercially available in 2019.

Transthoracic Parametric Doppler (TPD)

The Transthoracic Parametric Doppler (TPD) is a portable, simple to operate non-invasive ultrasound Doppler system. All data acquisition and signal processing is automatic and provides heathcare providers with immediate diagnoses. A unique feature of the TPD is that it is very easy to operate as it does not depend on the exact positioning of the ultrasound probe.


Feature Highlights

The EchoSense TPD includes these capabilities:

  • Non-Invasive diagnosis of Pulmonary Hypertension without the need for Cardiac Catheterization procedures.
  • Diagnosis of Congestive Heart Failure including fast and simple patient monitoring without the need of specialized medical staff.
  • Automatic, online and reliable diagnosis of Chronic Obstructive Pulmonary Disease (COPD).
  • Real-time detection of Cardiac Arrhythmias.

EchoSense D-Holter

The EchoSense D-Holter registers Doppler signals that reflect cardiac mechanical compared to the electrical signals recorded by conventional ECG based Holter devices. This method minimizes most of the problems associated with standard ECG based Holter devices.

Feature Highlights

The D-Holter has several advantages over standard (ECG) Holter devices:

  • The signals recorded by the D-Holter during an episode of AFib are clearly distinguishable and enable diagnosis of with very high sensitivity and specificity.
  • The cardiac rhythm signals recorded by the D-Holter are relatively insensitive to subject movement, muscle electric and mechanical activity, and ambient electric noise pick-up.
  • The D-Holter requires a single patch sensor and eliminates patient discomfort due to the multiple electrodes required for reliable Afib detection. This enables long-term recording for detection of episodes of intermittent AF activity.
  • The position of the patch is not critical and is easily reapplied by the patient.